GlassScriptPhysician profile
Iryna Popiv
NPI 1750874343
$4,626.56
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,850 · 2024: $2,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863 · Travel and Lodging: $1,764 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.67 |
| Travel and Lodging | $1,763.89 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,983.59 | 2024 | Echelon Flex |
| Intuitive Surgical, INC. | $1,234.16 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $374.51 | 2023-2024 | Echelon Flex, Harmonic, Enseal |
| Medtronic, INC. | $294.37 | 2023-2024 | Signia |
| W. L. Gore & Associates, INC. | $275.84 | 2023-2024 | Seamguard, Gore Enform Preperitoneal Biomaterial |
| Virtual Incision Corporation | $140.00 | 2024 | Mira |
| Teleflex LLC | $106.35 | 2023 | Titan Sgs Standard Gastric Stapler |
| Kerecis Limited | $98.48 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Asensus Surgical, INC. | $93.91 | 2024 | Senhance |
| Takeda Pharmaceuticals U.S.A., INC. | $25.35 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iryna Popiv listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.